Diagnostics for latent TB infection: incremental, not transformative progress

Pai Madhukar, Sotgiu Giovanni

Source: Eur Respir J 2016; 47: 704-706
Journal Issue: March

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Pai Madhukar, Sotgiu Giovanni. Diagnostics for latent TB infection: incremental, not transformative progress. Eur Respir J 2016; 47: 704-706

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnostics of the latent TBC infection (LTBI) activity in children
Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood
Year: 2011

Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection
Source: Eur Respir J 2010; 36: 1242-1247
Year: 2010



Latent tuberculosis infection (LTBI) treatment completion and complication in Leeds, UK
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011

A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014



The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005

Advancing global programmatic management of latent tuberculosis infection for at risk populations
Source: Eur Respir J 2016; 47:1327-1330
Year: 2016


Direct costs of three models for the screening of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 45-50
Year: 2006



The effectiveness of programmatic management of latent tuberculosis infection in the Netherlands
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015


Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection
Source: Eur Respir J 2010; 36: 135-142
Year: 2010



Screening migrants for tuberculosis and latent TB infection: the reward will come later
Source: Eur Respir J, 54 (4) 1901719; 10.1183/13993003.01719-2019
Year: 2019



Incidence of TB latent infection in health care workers in a low TB prevalence country
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005


New guidelines for screening for tuberculosis and latent tuberculosis infection pre-immunosuppressive therapy in the Netherlands: a targeted and stratified approach
Source: International Congress 2019 – Tuberculosis: diagnosis and scores
Year: 2019


HIV testing in new patients with TB: attitudes and action in the U.K. in 2006
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007


The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results
Source: Eur Respir J 2011; 38: 1374-1381
Year: 2011



TB as an occupational disease
Source: Eur Respir Mon 2012; 58: 219-229
Year: 2012


A combinatorial dual-immunoassay predicts reactivation risk for patients with previously incomplete treatment for latent tuberculosis infection
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016


Risk of latent tuberculosis infection among healthcare trainees
Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features
Year: 2012


What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009


Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice
Source: Eur Respir J 2011; 37: 1175-1182
Year: 2011